chr9-78236351-A-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_001330691.3(CEP78):c.1A>T(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.000000705 in 1,418,920 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 7.0e-7 ( 0 hom. )
Consequence
CEP78
NM_001330691.3 start_lost
NM_001330691.3 start_lost
Scores
3
8
5
Clinical Significance
Conservation
PhyloP100: 5.36
Genes affected
CEP78 (HGNC:25740): (centrosomal protein 78) This gene encodes a centrosomal protein that is both required for the regulation of centrosome-related events during the cell cycle, and required for ciliogenesis. The encoded protein has an N-terminal leucine-rich repeat (LRR) domain with six consecutive LRR repeats, and a C-terminal coiled-coil domain. It interacts with the N-terminal catalytic domain of polo-like kinase 4 (PLK4) and colocalizes with PLK4 to the distal end of the centriole. Naturally occurring mutations in this gene cause defects in primary cilia that result in retinal degeneration and sensorineural hearing loss which are associated with cone-rod degeneration disease as well as Usher syndrome. Low expression of this gene is associated with poor prognosis of colorectal cancer patients. [provided by RefSeq, Mar 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CEP78 | NM_001330691.3 | c.1A>T | p.Met1? | start_lost | 1/17 | ENST00000643273.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CEP78 | ENST00000643273.2 | c.1A>T | p.Met1? | start_lost | 1/17 | NM_001330691.3 | P4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 7.05e-7 AC: 1AN: 1418920Hom.: 0 Cov.: 30 AF XY: 0.00000142 AC XY: 1AN XY: 703194
GnomAD4 exome
AF:
AC:
1
AN:
1418920
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
703194
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 30, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 2018416). This variant has not been reported in the literature in individuals affected with CEP78-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change affects the initiator methionine of the CEP78 mRNA. The next in-frame methionine is located at codon 88. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Benign
DEOGEN2
Benign
T;.;.;.;.;.;.;.;.;T;.;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D;D;D;.;D;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationTaster
Benign
D;D;D;D
PROVEAN
Benign
N;.;.;.;.;.;.;N;N;N;.;.;.;N
REVEL
Uncertain
Sift
Pathogenic
D;.;.;.;.;.;.;D;D;D;.;.;.;D
Sift4G
Pathogenic
D;.;.;.;.;.;.;D;D;D;.;.;.;D
Polyphen
D;.;.;.;.;.;.;.;P;.;.;.;.;.
Vest4
MutPred
Loss of ubiquitination at K6 (P = 0.1083);Loss of ubiquitination at K6 (P = 0.1083);Loss of ubiquitination at K6 (P = 0.1083);Loss of ubiquitination at K6 (P = 0.1083);Loss of ubiquitination at K6 (P = 0.1083);Loss of ubiquitination at K6 (P = 0.1083);Loss of ubiquitination at K6 (P = 0.1083);Loss of ubiquitination at K6 (P = 0.1083);Loss of ubiquitination at K6 (P = 0.1083);Loss of ubiquitination at K6 (P = 0.1083);Loss of ubiquitination at K6 (P = 0.1083);Loss of ubiquitination at K6 (P = 0.1083);Loss of ubiquitination at K6 (P = 0.1083);Loss of ubiquitination at K6 (P = 0.1083);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at